Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile -: Associated disease caused by the hypervirulent NAP1/027 strain

被引:241
作者
Valiquette, Louis
Cossette, Benoit
Garant, Marie-Pierre
Diab, Hassan
Pepin, Jacques
机构
[1] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada
[2] CHU Sherbrooke, Dept Pharm, Sherbrooke, PQ J1H 5N4, Canada
[3] CHU Sherbrooke, Clin Res Ctr, Sherbrooke, PQ J1H 5N4, Canada
关键词
D O I
10.1086/519258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A series of measures were implemented, in a secondary/tertiary-care hospital in Quebec, to control an epidemic of nosocomial Clostridium difficile-associated disease (n-CDAD) caused by a virulent strain; these measures included the development of a nonrestrictive antimicrobial stewardship program. Interrupted time-series analysis was used to evaluate the impact of these measures on n-CDAD incidence. From 2003-2004 to 2005-2006, total and targeted antibiotic consumption, respectively, decreased by 23% and 54%, and the incidence of n-CDAD decreased by 60%. No change in n-CDAD incidence was noted after strengthening of infection control procedures (P = .63), but implementation of the antimicrobial stewardship program was followed by a marked reduction in incidence (P = .007). This suggests that nonrestrictive measures to optimize antibiotic usage can yield exceptional results when physicians are motivated and that such measures should be a mandatory component of n-CDAD control. The inefficacy of infection control measures targeting transmission through hospital personnel might be a result of their implementation late in the epidemic, when the environment was heavily contaminated with spores.
引用
收藏
页码:S112 / S121
页数:10
相关论文
共 37 条
[1]   Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 [J].
Archibald, LK ;
Banerjee, SN ;
Jarvis, WR .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (09) :1585-1589
[2]   Risk factors for Clostridium difficile infection [J].
Bignardi, GE .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) :1-15
[3]   Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus [J].
Bosso, John A. ;
Mauldin, Patrick D. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2106-2112
[4]   Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years [J].
Carling, P ;
Fung, T ;
Killion, A ;
Terrin, N ;
Barza, M .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (09) :699-706
[5]   Hospital-wide restriction of clindamycin:: Effect on the incidence of Clostridium difficile-associated diarrhea and cost [J].
Climo, MW ;
Israel, DS ;
Wong, ES ;
Williams, D ;
Coudron, P ;
Markowitz, SM .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) :989-+
[6]   Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II) [J].
de With, K ;
Bergner, J ;
Bühner, R ;
Dörje, F ;
Gonnermann, C ;
Haber, M ;
Hartmann, M ;
Rothe, U ;
Strehl, E ;
Steib-Bauert, M ;
Kern, WV .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (03) :213-218
[7]  
DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.2307/2332325
[8]   An additional measure for quantifying antibiotic use in hospitals [J].
Filius, PMG ;
Liem, TBY ;
van der Linden, PD ;
Janknegt, R ;
Natsch, S ;
Vulto, AG ;
Verbrugh, HA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) :805-808
[9]   Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use [J].
Gaynes, R ;
Rimland, D ;
Killum, E ;
Lowery, HK ;
Johnson, TM ;
Killgore, G ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :640-645
[10]  
GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459